ArticleJournal of the National Cancer Institute2026

Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort.

Daniel J Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.